Close Menu

NEW YORK (GenomeWeb) – A team led by researchers at the Spanish National Cancer Research Center and Utrecht University have identified a set of protein kinases that are predictive of treatment outcomes in triple-negative breast cancer.

Published today in Nature Communications, the study used a combination of mass spec-based phosphoproteomics and immunohistochemistry to identify six kinases whose activation levels can help predict the likelihood of relapse and guide therapy in TNBC.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.